Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Jianyuan Pharmaceutical Technology Co., Ltd. is a specialized biotechnology company focused on the innovation of peptide-based drugs and advanced drug delivery systems. Established in 2009 and part of the Star Silver Investment Group, the company leverages its proprietary platforms to develop sustained-release formulations, particularly microsphere-based delivery for proteins and polypeptides. Its research portfolio targets high-prevalence conditions including metabolic disorders and oncology. With integrated R&D and manufacturing capabilities across Beijing, Shenzhen, and Nanjing, the company aims to provide high-quality, innovative pharmaceutical products for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Jianyuan Pharmaceutical.